Literature DB >> 23651316

Anti-H5N1 virus flavonoids from Capparis sinaica Veill.

Amany K Ibrahim1, Ahmed I Youssef, Abdel Satar Arafa, Safwat A Ahmed.   

Abstract

Methanolic extract of Capparis sinaica Veill was tested for its in vitro antiviral activity against highly pathogenic avian influenza strain H5N1 using plaque inhibition assay in Madin-Darby canine kidney. The results indicated that the extract possessed potent antiviral activity (100% inhibition at the concentration of 1 μg/ml). Based on this result, C. sinaica Veill was selected for further study by applying bioactivity-guided fractionation to isolate its antiviral principles. The fractions eluted with EtOAc and 25% MeOH in EtOAc were found to hold the antiviral activity. Further chromatographic separation of the fractions holding the antiviral activity led to the isolation of quercetin (1), isoquercetin (2) and rutin (3) for the first time from this species. The isolates showed reduction in the virus titre by 68.13%, 79.66% and 73.22% inhibition at a concentration of 1 ng/ml, respectively.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23651316     DOI: 10.1080/14786419.2013.790027

Source DB:  PubMed          Journal:  Nat Prod Res        ISSN: 1478-6419            Impact factor:   2.861


  11 in total

1.  In silico identification and in vitro antiviral validation of potential inhibitors against Chikungunya virus.

Authors:  Jyoti Verma; Abdul Hasan; Sujatha Sunil; Naidu Subbarao
Journal:  J Comput Aided Mol Des       Date:  2022-07-05       Impact factor: 4.179

2.  An extract from Taxodium distichum targets hemagglutinin- and neuraminidase-related activities of influenza virus in vitro.

Authors:  Chung-Fan Hsieh; Yu-Li Chen; Chwan-Fwu Lin; Jin-Yuan Ho; Chun-Hsun Huang; Cheng-Hsun Chiu; Pei-Wen Hsieh; Jim-Tong Horng
Journal:  Sci Rep       Date:  2016-10-31       Impact factor: 4.379

Review 3.  The Pharmacological Potential of Rutin.

Authors:  Aditya Ganeshpurkar; Ajay K Saluja
Journal:  Saudi Pharm J       Date:  2016-04-30       Impact factor: 4.330

Review 4.  Potential Natural Products Against Respiratory Viruses: A Perspective to Develop Anti-COVID-19 Medicines.

Authors:  Marzieh Omrani; Mohsen Keshavarz; Samad Nejad Ebrahimi; Meysam Mehrabi; Lyndy J McGaw; Muna Ali Abdalla; Parvaneh Mehrbod
Journal:  Front Pharmacol       Date:  2021-02-17       Impact factor: 5.810

Review 5.  Isoquercetin as an Anti-Covid-19 Medication: A Potential to Realize.

Authors:  Majambu Mbikay; Michel Chrétien
Journal:  Front Pharmacol       Date:  2022-03-02       Impact factor: 5.810

Review 6.  Effects of Plant Metabolites on the Growth of COVID-19 (Coronavirus Disease-19) Including Omicron Strain.

Authors:  Hiroj Bagde; Ashwini Dhopte
Journal:  Cureus       Date:  2022-07-04

7.  Antiviral and Antioxidant Activity of a Hydroalcoholic Extract from Humulus lupulus L.

Authors:  Antonella Di Sotto; Paola Checconi; Ignacio Celestino; Marcello Locatelli; Stefania Carissimi; Marta De Angelis; Valeria Rossi; Dolores Limongi; Chiara Toniolo; Lucia Martinoli; Silvia Di Giacomo; Anna Teresa Palamara; Lucia Nencioni
Journal:  Oxid Med Cell Longev       Date:  2018-07-24       Impact factor: 6.543

Review 8.  Antiviral effect of phytochemicals from medicinal plants: Applications and drug delivery strategies.

Authors:  Shimon Ben-Shabat; Ludmila Yarmolinsky; Daniel Porat; Arik Dahan
Journal:  Drug Deliv Transl Res       Date:  2020-04       Impact factor: 4.617

Review 9.  The upshot of Polyphenolic compounds on immunity amid COVID-19 pandemic and other emerging communicable diseases: An appraisal.

Authors:  Ayman Khalil; Diana Tazeddinova
Journal:  Nat Prod Bioprospect       Date:  2020-10-15

10.  Identification of Potential SARS-CoV-2 Main Protease and Spike Protein Inhibitors from the Genus Aloe: An In Silico Study for Drug Development.

Authors:  Mohamed E Abouelela; Hamdy K Assaf; Reda A Abdelhamid; Ehab S Elkhyat; Ahmed M Sayed; Tomasz Oszako; Lassaad Belbahri; Ahmed E El Zowalaty; Mohamed Salaheldin A Abdelkader
Journal:  Molecules       Date:  2021-03-21       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.